Advantages and disadvantages of mammography screening

Breast Care

Volumn 6, Issue 3, 2011, Pages 199-207

  Heywang Köbrunner, Sylvia H ^a   Hacker, Astrid ^a   Sedlacek, Stefan ^a  

^a Referenzzentrum Mammographie München ^*  (Germany)

Author keywords

Advantages; Disadvantages; Mammography; Mortality reduction; Overdiagnosis; Screening

Indexed keywords

AWARENESS; BREAST CANCER; CANCER DIAGNOSIS; CANCER MORTALITY; CANCER REGISTRY; CANCER SCREENING; DIAGNOSTIC TEST ACCURACY STUDY; ECHOMAMMOGRAPHY; GERMANY; HEALTH CARE QUALITY; HISTOPATHOLOGY; HUMAN; MAMMOGRAPHY; MEDICAL DOCUMENTATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; RADIATION HAZARD; REVIEW; SENSITIVITY AND SPECIFICITY;

EID: 79959868007     PISSN: 16613791     EISSN: 16613805     Source Type: Journal    
DOI: 10.1159/000329005     Document Type: Review

References (45)

1. www.tumorregister-muenchen.de/facts/surv/surv- C50f-G.pdf.
2. Becker N, Junkermann H: Nutzen und Risiko des Mammographiescreenings. Dt Ärzteblatt 2008; 105:131-36.
3. Nelson HD, Tyne K, Naik A, et al.: Screening for breast cancer can update for the US Preventive Services Task Force. Ann Int Med 2009;151:727-42.
4. Gøtzsche PC, Nielsen M: Screening for breast cancer with mammography. Cochrane Database Syst Rev 2009;(4):CD001877
5. Gøtzsche PC, Olsen O: Is screening for breast cancer with mammography justifiable? Lancet 2000; 355:129-34 (Pubitemid 30068564)
6. Richtlinien des Bundesausschusses der Ärzte und Krankenkassen über die Früherkennung von Krebserkrankungen (, Krebsfrüherkennungs-Richtlinien'): www.mammo-programm.de/service/ infomaterial-fachservice.php.
7. Perry N, Broeders M, De Wolf C, Törrberg S, et al. (eds): European Guidelines for Quality Assurance in Mammography Screening, 4th ed. Office for Official Publications of the European Communities, Luxembourg, 2006.
8. Heywang-Köbrunner SH, Schreer I, Heindel W, Katalinic A: Bildgebung für die Brustkrebsfrüh-erkennung. Dtsch Ärztebl Int 2008;105:541-7.
9. Duffy SW, Tabar L, Olsen AH, et al.: Absolute numbers of lives saved and overdiagnosis in breast cancer screening, from a randomised trial and from the breast screening programme in England. J Med Screen 2010;17:25-30.
10. National Academy of Sciences: Health risks from exposure to low levels of ionizing radiation: BEIR VII-phase 2. Washington DC, National Academies Press, 2006.
11. Strahlenschutzkommission: Evaluierung von Nut-zen und Risiken im qualitätsgesicherten Mammo-graphie-Screening in Deutschland. Empfehlung der Strahlenschutzkommission, 2010. www.ssk.de.
12. Yaffe MJ, Mainprize JG: Risk of radiation-induced breast cancer from mammographic screening. Radiology 2011;258:98-105.
13. Heywang-Köbrunner, Hacker A, Sedlacek S, Engel J: Mammographie-Screening-eine Zwi-schenbilanz. Gyn und Gebhilfe 2010;7:31-8.
14. www.mammo-programm.de.
15. Qualitätsbericht des Mammographie-Screening-Programms von 2005-2007. www.mammo-pro-gramm.de/service/infomaterial-fachservice.php.
16. Brewer NT, Salz T, Lillie SE: Systematic review: the long-term effects of false-positive mammo-grams. Ann Intern Med 2007;146:502-10. (Pubitemid 351650559)
17. Armstrong K, Moye E, Williams S, Berlin JA, Reynolds EE: Screening mammography in women 40 to 49 years of age: a systematic review for the American College of Physicians. Ann Intern Med 2007;146:516-26.
18. Salz T, Richman AR, Brewer NT: Meta-analy-ses of the effect of false-positive mammograms on generic and specific psychosocial outcomes. Psychooncology 2010;19:1026-34.
19. Hofvind S, Geller B, Skaane P: Mammographic features and histopathological findings of interval breast cancers. Acta Radiol 2008;49:975-81.
20. Boyd NF, Guo H, Martin LJ, et al.: Mammographic breast density and the risk and detection of breast cancer. N Eng J Med 2007;356:297-300.
21. Mandelson MT, Oestreicher N, Porter PL, White D, Finder CA, Taplin SH, White E: Breast density as a predictor of mammographic detection: comparison of interval-and screen-detected cancers. J Natl Cancer Inst 2000;92:1081-7. (Pubitemid 30616482)
22. Braisch U, Geiss K, Meyer M: Bevölkerungsbezo-gene Betrachtung der Tumorstadienverschiebungen durch Mammographie-Screening in ver schiede nen histologischen Untergruppen. www.ekr.med.uni-erlangen.de/GEKID/Vortraege/ GMDS2010- VortragBraisch.pdf.
23. Zahl PH, Maehlen J. Welch HG: The natural history of invasive breast cancers detected by screening mammography. Arch Int Med 2008; 168:2311-6.
24. Paci et al, Wedon-Fekjoer et al, Kalager M, et al.: Rapid responses to Zahl PH, Maehlen J, Welch HG (Arch Int Med 2008; 168:2311-6). Arch Int Med 2009; 169: 997-9.
25. Puliti D, Zappa M, Miccinesi G, et al.: An estimate of overdiagnosis 15 years after the start of mammographic screening in Florence. Eur J Cancer 2009;45:3166-71.
26. De Koning HJ, Draisma G, Fracheboud J, de Bruijm A: Overdiagnosis and overtreatment of breast cancer: microsimulation modelling estimates based on observed screen and clinical data. Breast Cancer Res 2006;8:202.
27. Zackrisson S, Andersson I, Janzon L, et al.: Rate of over-diagnosis of breast cancer 15 years after end of Malmö mammographic screening trial: follow-up study. BMJ 2006;332:689-92.
28. Jørgensen KJ, Gøtzsche PC: Overdiagnosis in publicly organised mammography screening programmes: systematic review of incidence trends. BMJ 2009;339:b2587. Review.
29. Pisani P, Foreman D, et al.: (Rapid responses to Jørgensen KJ, Gøtzsche PC BMJ 2009). BMJ 2009. www.bmj.com/content/339/bmj.b2587/reply.
30. Euler-Chelpin M, Njor SH, et al.: (Rapid responses to Jørgensen KJ, Gøtzsche PC BMJ 2009). BMJ 2009. www.bmj.com/cgi/eletters/339/jul09- b2587.
31. Kopans DB: A Major error. BMJ 2009. www.bmj. com/cgi/eletters/339/jul09- 1/b2587#217871.
32. International Agency for research on Cancer (WHO), press release no.139 19-03-02: Mammo-graphy screening can reduce deaths from breast cancer. www.iarc.fr/en/media-centre/pr/2002/pr139. html.
33. The Swedish Organized Screening Evaluation Group: Reduction in breast cancer mortality from organized service screening with mammography: further confirmation with extended data. And validation with alternative analytic methods. Cancer Epidemiol Biomarkers Prev 2006;15:45-51.
34. Jonsson H, Bordás P, Wallin H, Nyström L, Lenner P: Service screening with mammography in Northern Sweden: effects on breast cancer mortality-an update. J Med Screen 2007;14:87-93. (Pubitemid 47067763)
35. Allgood PC, Warwick J, Warren RM, Day NE, Duffy SW: A case-control study of the impact of the East Anglian breast screening programme on breast cancer mortality. Br J Cancer 2008;98:206-9.
36. Parvinen I, Helenius H, Pylkkänen L, et al.: Service screening mammography reduces breast cancer mortality among elderly women in Turku. J Med Screen 2006;13:34-40. (Pubitemid 43843763)
37. Schopper D, deWolf C: How effective are breast cancer screening programmes by mammography? Review of the current evidence. Eur J Cancer 2009;45:1916-23.
38. Gabe R, Tryggvadottir L, Sigfusson BF, et al.: A case-control study to estimate the impact of the Icelandic population-based mammography screening program on breast cancer death. Acta Radiol 2007;48:948-55. (Pubitemid 350022989)
39. Roder D, Houssami N, Farshid G, et al.: Population screening and intensity of screening are associated with reduced breast cancer mortality: evidence of efficacy of mammography screening in Australia. Breast Cancer Res Treat 2008;108: 409-16. (Pubitemid 351431073)
40. Coldman A, Phillips N, Warren L, Kan L: Breast cancer mortality after screening mammography in British Columbia women. Int J Cancer 2007; 120:1076-80. (Pubitemid 46214308)
41. Van Schoor G, Moss SM, Otten JD, et al.: Increasingly strong reduction in breast cancer mortality due to screening. Br J Cancer 2011;104:910-4.
42. Berry DA, Cronin KA, Plevritis SK, et al.: Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med 2005;353:1784-92. (Pubitemid 41549890)
43. Vervoort MM, Draisma G, Fracheboud J, et al.: Trends in the usage of adjuvant systemic therapy for breast cancer in the Netherlands and its effect on mortality. Br J Cancer 2004;91:242-7. (Pubitemid 39037066)
44. Health Council of the Netherlands: The benefit of population screening for breast cancer with mammography. The Hague: Health Council of the Netherlands, 2002; publication no. 2002/03E. ISBN: 90-5549-420-8.
45. Holland R, Rijken H, Hendriks J: The Dutch population-based mammography screening: 30-year-experience. Breast Care 2007;2:12-8. (Pubitemid 46364551)